BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 6)
Staph

New antibiotic for treating MRSA, KIMYRSA, now commercially available

By

By NewsDesk  @infectiousdiseasenews Morristown, NJ pharmaceutical company, Melinta Therapeutics announced this week that their lipoglycopeptide antibiotic, KIMYRSA™ (oritavancin), is now commercially...

Antibiotic, Solosec, receives FDA approval as treatment of trichomoniasis

By

By NewsDesk  @infectiousdiseasenews Today, the U.S. Food and Drug Administration (FDA) approved Lupin Pharmaceuticals supplemental New Drug Application (sNDA) to expand the use of SOLOSEC® (secnidazole)...

Anti-infective therapy for infections caused by drug-resistant gram-negative pathogens now in Phase I study

By

By NewsDesk  @infectiousdiseasenews Biopharmaceutical company, Qpex Biopharma, announced this week the initiation of a Phase 1 study of QPX9003, a next generation intravenous (IV)-administered synthetic...

Lyme disease prevention: Tarsus Pharmaceuticals initiates clinical trial for oral, non-vaccine TP-05

By

By NewsDesk  @infectiousdiseasenews TP-05 is designed to kill infected ticks attached to the human body before they can transmit the Borrelia bacteria that causes Lyme disease Late clinical-stage biopharmaceutical...

Monoclonal antibody prevents HIV infection in monkeys, study finds

By

An experimental, lab-made antibody can completely prevent nonhuman primates from being infected with the monkey form of HIV, new research published in Nature Communications shows. The results will inform...

Smallpox drug, Tembexa, receives FDA approval

By

By NewsDesk  @infectiousdiseasenews The U.S. Food and Drug Administration Friday approved Tembexa (brincidofovir) to treat smallpox. Although the World Health Organization declared smallpox, a contagious...

Malaysia starts Ivermectin trial for high risk COVID-19 patients

By

By NewsDesk  @infectiousdiseasenews Effective pharmacologic treatments for COVID-19 remains a challenge. The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial showed dexamethasone, a steroid,...

Malaysia officials respond to ivermectin ‘miracle drug’ claims

By

By NewsDesk  @infectiousdiseasenews Ivermectin is an anti-parasitic drug mostly used in veterinary medicine, especially treating worm infestations. In April 2020, researchers using laboratory methods...

Ivermectin is highly effective as a safe prophylaxis and treatment for COVID-19: Comprehensive review

By

Peer reviewed by medical experts that included three U.S. government senior scientists and published in the American Journal of Therapeutics, the research is the most comprehensive review of the available...

Lyme disease investigational drug: FDA accepts IND application

By

By NewsDesk  @infectiousdiseasenews Biopharmaceutical company, Tarsus Pharmaceuticals, recently announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s Investigational...